TruBridge, Inc.
TBRG · Price history
Company & revenue
About TruBridge, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement. The company places a strong emphasis on its RCM offerings, which are designed to integrate seamlessly with any primary healthcare information solutions provider.
How they make money
TruBridge generates revenue primarily through the provision of healthcare technology solutions and revenue cycle management services. The company operates under a business model that includes recurring software-as-a-service (SaaS) subscriptions, managed services, and professional services, primarily targeting rural and community healthcare organizations in the United States.
Products & services
The company provides an integrated suite of healthcare technology solutions, including electronic health records (EHR), revenue cycle management (RCM) services, practice management software, and various acute care support and maintenance services.
Brands & revenue mix
Core software solution platform for community hospitals.
Separate brand revenue is not available in this research.Source
Patient health record solution.
Separate brand revenue is not available in this research.Source
Healthcare database and management solution.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- Cloud Infrastructure Providers — The company relies on third-party cloud hosting and data center services to support its software platforms and EHR solutions; specific supplier names are not disclosed.Source
Competitors
Strengths
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
26
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
42
Weak
Financial Strength
68
Business Quality / Moat
30
Management
38
Growth Quality
27
Risk / Durability
24
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
27
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
32/100
Building Historical Record
Model Score 32/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for TBRG
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving TBRG's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is TBRG's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is TBRG's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify TBRG's current valuation?
Essential Investment Snapshot
Wall Street Score
26
Opportunity Score
27
Market Cap
$393.6M
P/E Ratio
89.3
EPS
$0.29
52-Week High
$26.51
52-Week Low
$13.88
Beta
1.29
Intrinsic Value
$3.68
Analyst Target
$26.25
Shares Outstanding
14.5M
Total Revenue
$345.9M
Total Debt
$168.5M
Dividend
No current dividend
Liquidation Value / Share
$12.33
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Notices for TBRG
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Debt service risk
Interest coverage is low (~1.7x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on TBRG.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Specialized focus on rural and community healthcare markets.
- +Integrated suite of revenue cycle and EHR technology.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
- −Dependence on third-party cloud and technology infrastructure.
- −Regulatory changes in the healthcare industry.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
3 historical score records availablePrevious Score
26
Oct 1, 2026
Change
Unchanged
Current Score
26
Oct 22, 2026
Category Changes
TBRG score was unchanged.
Projected Score
Projected Score
31
Projected Change
+4.8 points
Preliminary comparable-period financial changes suggest improvement of approximately 4.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$26.24
Model Intrinsic Value
$3.68
Difference
+$22.56
+612.3% vs IV
Margin of Safety
-612.3%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $345.9M | $346.8M | $342.6M | $339.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $168.7M | $163.0M | $168.5M | $175.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $177.2M | $183.9M | $174.1M | $163.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $39.9M | $32.6M | $34.5M | $37.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $109.9M | $104.2M | $104.1M | $104.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $156.6M | $163.0M | $167.5M | $206.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $32.6M | $42.5M | $34.9M | -$15.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $20.6M | $20.8M | $6.6M | -$42.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $6.3M | $12.3M | $16.2M | $12.5M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$471K | $3.9M | -$10.2M | -$54.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | -$4.9M | -$485K | $10.2M | -$8.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $4.4M | $4.4M | -$20.4M | -$45.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $0.29 | $0.29 | $-1.38 | $-3.15 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 14.56M | 14.49M | 14.30M | 14.19M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 14.56M | 14.49M | 14.30M | 14.19M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$86.3M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.03
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-1.4%
Cash Change
+249.9%
Margin Change
+0.1 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
- Debt reduced
Potential Score Impact
Positive indicators included EPS growth, cash levels, debt levels, net income margin. Pressure indicators included revenue growth. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 1.1%. EPS increased 9.7%. Cash increased 249.9%. Total debt declined 1.4%. Net income margin improved by 0.1 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
3 historical recordsHistorical Score Chart
3 of 3 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare Information ServicesNews
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
ROSEN, A LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
Rumor Mill · TBRG
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial